Research News

---

Topic: Chemotherapy (view all topics)

Tags for topic Chemotherapy:

• Abraxane (chemical name: paclitaxel)
• Adjuvant
• Adriamycin (chemical name: doxorubicin)
• Anthracyclines
• carboplatin (brand name: Paraplatin)
• Cytoxan (chemical name: cyclophosphamide)
• daunorubicin (brand names: Cerubidine, DaunoXome)
• Dose Dense
• Doxil (chemical name: doxorubicin)
• Ellence (chemical name: epirubicin)
• fluorouracil (also called 5-fluorouracil or 5-FU; brand name: Adrucil)
• Halaven (chemical name: eribulin)
• Ixempra (chemical name: ixabepilone)
• mitoxantrone (brand name: Novantrone)
• Navelbine (chemical name: vinorelbine)
• Neoadjuvant
• Standard
• Taxanes
• Taxol (chemical name: paclitaxel)
• Taxotere (chemical name: docetaxel)
• Xeloda (chemical name: capecitabine)

View articles by month and year

• Scientists Report on New Breast Cancer Treatments

  Published on January 23, 2009 at 12:00 am

  • Tags: Abraxane (chemical name: paclitaxel), Ixempra (chemical name: ixabepilone), and Standard

  A number of studies are looking at new ways to treat breast cancer, including testing the effectiveness of new compounds and new uses for current medicines.

• Ixempra Approved to Treat Advanced-Stage Breast Cancer

  Published on October 17, 2007 at 12:00 am

  • Tags: Ixempra (chemical name: ixabepilone), Xeloda (chemical name: capecitabine), and Standard

  Ixempra (chemical name: ixabepilone) has been approved by the U.S. Food and Drug Administration to treat advanced breast cancers after other chemotherapy medicines have stopped working.

• Ixabepilone Gets Faster Review

  Published on June 19, 2007 at 12:00 am

  • Tags: Ixempra (chemical name: ixabepilone) and Standard

  Ixabepilone, a new chemotherapy medication for advanced breast cancer, has been given priority review by the U.S. Food and Drug Administration.